Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease-Reference-Cited by-同舟云学术

Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease

Published:2020-06-12 Issue:8 Volume:40 Page:1941-1951
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Viveiros André¹,Panzer Marlene¹,Baumgartner Nadja¹,Schaefer Benedikt¹,Finkenstedt Armin¹,Henninger Benjamin²,Theurl Igor³,Nachbaur Karin¹,Weiss Günter³,Haubner Roland⁴,Decristoforo Clemens⁴,Tilg Herbert¹,Zoller Heinz¹^ORCID

Affiliation:

1. Department of Medicine I Medical University and University Hospital of Innsbruck Innsbruck Austria

2. Department of Radiology Medical University and University Hospital of Innsbruck Innsbruck Austria

3. Department of Medicine II Medical University and University Hospital of Innsbruck Innsbruck Austria

4. Department of Nuclear Medicine Medical University and University Hospital of Innsbruck Innsbruck Austria

Funder

Christian Doppler Forschungsgesellschaft

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14539

Reference39 articles.

1. Identification of Mutations in SLC40A1 That Affect Ferroportin Function and Phenotype of Human Ferroportin Iron Overload

2. Ferroportin disease: A systematic meta-analysis of clinical and molecular findings

3. Hemochromatosis: An endocrine liver disease

4. Iron Matryoshka—Haemochromatosis nested in Ferroportin Disease?

5. The ferroportin disease

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The dual loss and gain of function of the FPN1 iron exporter results in the ferroportin disease phenotype;Human Genetics and Genomics Advances;2024-10

2. The Spectra of Disease-Causing Mutations in the Ferroportin 1 (SLC40A1) Encoding Gene and Related Iron Overload Phenotypes (Hemochromatosis Type 4 and Ferroportin Disease);Human Mutation;2023-06-13

3. Apo- and holo-transferrin differentially interact with hephaestin and ferroportin in a novel mechanism of cellular iron release regulation;Journal of Biomedical Science;2023-06-06

4. Hemochromatosis as a secondary condition to systemic lupus erythematosus: A case report;International Journal of Rheumatic Diseases;2023-05-23

5. The metal ion hypothesis of Alzheimer’s disease and the anti-neuroinflammatory effect of metal chelators;Bioorganic Chemistry;2023-02